Inclusion Criteria:  Untreated stage II-III lung cancers with operable and resectable disease determined by a thoracic surgeon Histologic confirmation of disease at MSKCC Age 18 years or older Karnofsky Performance Status ≥ 70 Adequate bone marrow, liver and renal function, as specified below: Absolute Neutrophil Count (ANC) ≥ 1.5 x 10^9 /L Hemoglobin ≥ 8 g/dL Platelets ≥ 100 x 10^9 /L Serum total bilirubin ≤ 1.5 x upper limit of normal (ULN) (except for patients with documented Gilbert's Syndrome) AST and ALT ≤ 2.5 x ULN Serum creatinine ≤ 1.5 x upper limit of normal or creatinine clearance ≥ 60ml/min for patients with creatinine levels above institutional normal. Negative PPD test For women of child-bearing potential, negative pregnancy test within 14 days prior to starting treatment Men and women of childbearing age must be willing to use effective contraception while on treatment and for at least 3 months thereafter Presence of at least one site of measurable disease as defined by the Response Evaluation Criteria in Solid Tumors 1.1 Ability to provide written, informed consent. Legally Authorized Representatives are permitted.  Exclusion Criteria:  Presence of an FDA approved targeted therapy for patients with NSCLC harboring a genomic aberration for which an FDA-approved targeted therapy is indicated Hypersensitivity to platinum agents Ongoing use of investigational agents or use of investigational agents within the last four weeks Prior use of TNF-α inhibitor History of rheumatoid arthritis, inflammatory bowel disease, or psoriatic arthritis Baseline hearing deficit (CTCAE version 4.0 grade 2 or higher) Ongoing bacterial, viral, or antifungal infection requiring antimicrobial treatment with the exception of thrush Active tuberculosis or untreated, latent tuberculosis If a patient has signs, symptoms, or a history suggestive of active tuberculosis, evaluation by an infectious disease physician will be required and active tuberculosis ruled-out prior to enrollment. Acute or chronic Hepatitis B or C infection Known HIV infection requiring antiretroviral medications and those with AIDS Active herpes zoster infection Non-healed infected skin ulcers History of myocardial infarction or unstable angina within the past 12 months Ongoing use of other immunosuppressive medications, including oral steroids and excluding topical steroids Women who are breastfeeding Prior history of other malignancy with the exclusion of localized prostate cancer, non-melanomatous skin cancer, ductal carcinoma or lobular carcinoma in situ of the breast